差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

交易 Jaguar Health, Inc. - JAGX CFD

-
0%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 -
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024874%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.002651%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* N/A
開盤價* N/A
1 年變化* N/A
日範圍* N/A
52 周範圍 0.71-61.13
平均交易量(10 天) 4.16M
平均交易量(3 個月) 28.79M
市值 10.21M
市盈率 -100.00K
流通股 4.03M
收入 10.78M
EPS -58.95
股息(收益率 %) N/A
貝塔 1.91
下一個財報發布日期 May 8, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開

Jaguar Health, Inc. Events

时间(协调世界时) (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018 2017
總收入 4.335 9.385 5.77526 4.41615 4.36119
收入 4.335 9.385 5.77526 4.41615 4.36119
收入成本,共計 2.333 3.28 3.81581 2.76575 0.88041
毛利 2.002 6.105 1.95945 1.6504 3.48078
總營業費用 45.796 37.896 39.6643 34.5802 39.0853
銷售/一般/行政費用,總計 25.997 20.996 20.4389 22.1088 14.3314
研究與開發 15.079 6.413 5.81982 5.15475 4.26946
異常費用(收入) 2.387 7.207 9.58971 4.55093 19.604
營業收入 -41.461 -28.511 -33.889 -30.1641 -34.7241
利息收入(費用),非經營淨值 -10.374 -5.488 -4.72125 -2.29767 -0.51429
其他,淨值 -0.765 0.19 0.08083 0.31569 0.08855
稅前淨收入 -52.6 -33.809 -38.5294 -32.1461 -35.1499
稅後淨收入 -52.6 -33.809 -38.5394 -32.1461 -21.9686
未計算非常項目前的淨收益 -52.595 -33.809 -38.5394 -32.1461 -21.9686
淨收入 -52.595 -33.809 -38.5394 -32.1461 -21.9686
Total Adjustments to Net Income 0 -4.839 -6.18681
普通股股東可獲收益 (不含非經常性項目) -52.595 -38.648 -44.7262 -32.1461 -21.9686
普通股股東可獲收益 (含非經常性項目) -52.595 -38.648 -44.7262 -32.1461 -21.9686
攤薄淨收入 -52.595 -38.648 -44.7262 -32.1461 -21.9686
攤薄後加權平均股 0.59601 0.1717 0.02206 0.00093 0.01287
扣除特別項目的每股攤薄盈利 -88.2458 -225.09 -2027.26 -34495.6 -1707.42
Dividends per Share - Common Stock Primary Issue
每股正常攤薄盈利 -84.2408 -183.115 -1744.73 -29612.1 -717.051
非常規項目總計 0
少數股東權益 0.005
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
總收入 3.15 2.921 2.625 2.08 0.63
收入 3.15 2.921 2.625 2.08 0.63
收入成本,共計 0.613 0.456 0.455 0.469 0.617
毛利 2.537 2.465 2.17 1.611 0.013
總營業費用 13.046 9.4 16.566 12.902 10.159
銷售/一般/行政費用,總計 6.493 6.493 8.979 6.951 6.23
研究與開發 5.94 2.451 4.945 5.482 3.312
異常費用(收入) 0 0 2.187 0 0
營業收入 -9.896 -6.479 -13.941 -10.822 -9.529
利息收入(費用),非經營淨值 -2.555 -1.827 -5.054 -2.747 -2.643
其他,淨值 -0.158 -1.084 0.831 -0.749 -0.02
稅前淨收入 -12.609 -9.39 -18.164 -14.318 -12.192
稅後淨收入 -12.609 -9.39 -18.164 -14.318 -12.192
未計算非常項目前的淨收益 -12.52 -9.367 -17.986 -14.313 -12.192
淨收入 -12.52 -9.367 -17.986 -14.313 -12.192
Total Adjustments to Net Income 0 0
普通股股東可獲收益 (不含非經常性項目) -12.52 -9.367 -17.986 -14.313 -12.192
普通股股東可獲收益 (含非經常性項目) -12.52 -9.367 -17.986 -14.313 -12.192
攤薄淨收入 -12.52 -9.367 -17.986 -14.313 -12.192
攤薄後加權平均股 1.41781 1.06239 0.99178 0.61775 0.61105
扣除特別項目的每股攤薄盈利 -8.83053 -8.81695 -18.1351 -23.1696 -19.9525
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -8.83053 -8.81695 -15.9299 -23.1696 -19.9525
少數股東權益 0.089 0.023 0.178 0.005
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 28.434 17.792 9.52235 8.14994 3.7991
現金和短期投資 17.051 8.09 3.49543 2.56819 0.5207
現金等價物 0.5207
應收賬款總額,淨額 2.144 4.56 1.69458 1.0018 0.46904
Accounts Receivable - Trade, Net 1.709 4.532 1.69171 0.99568 0.46766
Total Inventory 4.9 2.782 2.12869 3.34218 2.07282
Prepaid Expenses 4.339 2.36 1.26274 1.23777 0.49737
Other Current Assets, Total 0 0.94091 0 0.23917
Total Assets 53.265 42.843 36.4104 41.042 43.6292
Property/Plant/Equipment, Total - Net 1.734 0.677 0.71021 0.76062 1.22207
Other Long Term Assets, Total 0.446 0.037 0.15397 0.42083 0
Total Current Liabilities 15.471 13.22 15.3924 26.6588 15.3858
Accounts Payable 4.929 4.759 5.35154 5.41426 7.35493
Accrued Expenses 7.357 4.493 3.2589 4.93944 2.19955
Notes Payable/Short Term Debt 0 0 0 4.84558 1.14115
Current Port. of LT Debt/Capital Leases 3.184 3.789 6.77846 11.2392 4.28146
Other Current Liabilities, Total 0.001 0.179 0.00349 0.22038 0.40867
Total Liabilities 41.654 25.641 15.8424 26.6588 26.3682
Total Long Term Debt 25.022 12.421 0.45 0 10.9824
Long Term Debt 25.022 12.421 0.45 0 10.9824
Other Liabilities, Total 0.919 0
Total Equity 11.611 17.202 20.568 14.3831 17.261
Redeemable Preferred Stock 0 0 11.6065 9 0
Common Stock 0.005 0.011 0.00546 0.00649 0.01053
Additional Paid-In Capital 231.1 184.09 142.046 99.9274 79.6552
Retained Earnings (Accumulated Deficit) -219.494 -166.899 -133.09 -94.5508 -62.4047
Total Liabilities & Shareholders’ Equity 53.265 42.843 36.4104 41.042 43.6292
Total Common Shares Outstanding 50.4733 40.1279 45.0589 40.4184 42.6378
Goodwill, Net 0 5.21082
Intangibles, Net 22.651 24.337 26.0239 31.7106 33.3972
Cash 17.051 8.09 3.49543 2.56819
Property/Plant/Equipment, Total - Gross 2.032 0.942 0.93428
Accumulated Depreciation, Total -0.298 -0.265 -0.22407
Total Preferred Shares Outstanding 0 0 5.53706
Minority Interest 0.242
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 28.474 28.434 24.005 44.294 44.104
現金和短期投資 17.456 17.051 12.375 21.992 32.25
Cash 17.456 17.051 12.375 21.992 32.25
應收賬款總額,淨額 2.255 2.144 2.205 4.174 5.927
Accounts Receivable - Trade, Net 1.795 1.709 2.111 4.134 5.897
Total Inventory 4.879 4.9 4.513 3.402 2.821
Prepaid Expenses 3.884 4.339 4.912 4.806 3.106
Other Current Assets, Total 9.92 0
Total Assets 52.906 53.265 59.255 69.539 68.713
Property/Plant/Equipment, Total - Net 1.757 1.734 1.7 1.751 0.674
Property/Plant/Equipment, Total - Gross 2.18 2.032 1.99 2.033 0.948
Accumulated Depreciation, Total -0.423 -0.298 -0.29 -0.282 -0.274
Intangibles, Net 22.229 22.651 23.072 23.494 23.916
Other Long Term Assets, Total 0.446 0.446 10.478 0 0.019
Total Current Liabilities 19.093 15.471 11.951 12.652 12.592
Accounts Payable 3.708 4.929 3.786 4.918 4.74
Accrued Expenses 8.494 7.357 6.381 6.582 6.409
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6.89 3.184 1.781 1.145 1.431
Other Current Liabilities, Total 0.001 0.001 0.003 0.007 0.012
Total Liabilities 44.861 41.654 37.703 37.754 36.822
Total Long Term Debt 24.783 25.022 24.926 24.195 24.23
Long Term Debt 24.783 25.022 24.926 24.195 24.23
Total Equity 8.045 11.611 21.552 31.785 31.891
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.008 0.005 0.005 0.014 0.013
Additional Paid-In Capital 245.517 231.1 226.728 224.76 210.786
Retained Earnings (Accumulated Deficit) -237.48 -219.494 -205.181 -192.989 -178.908
Total Liabilities & Shareholders’ Equity 52.906 53.265 59.255 69.539 68.713
Total Common Shares Outstanding 79.1948 50.4733 48.2117 47.8944 44.7563
Total Preferred Shares Outstanding 0 0 0 0 0
Other Liabilities, Total 0.921 0.919 0.826 0.907
Minority Interest 0.064 0.242
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 -52.6 -33.809 -38.5394 -32.1461 -21.9686
經營活動産生的現金 -34.97 -15.278 -20.4568 -22.7308 -9.82494
經營活動産生的現金 1.719 1.727 1.73708 1.319 0.58434
非現金物品 13.644 20.271 17.0073 9.02132 20.6123
已付現金利息 0.028 0.757 0.142 0.01934 0.23455
營運資金的變化 2.267 -3.467 -0.66177 -0.9251 4.12831
投資活動産生的現金 -0.006 -0.007 0 -0.00653 -1.55734
資本支出 -0.006 -0.007 -0.00653 0
其他投資現金流量項目,總計 0 0 -1.55734
融資活動産生的現金 43.937 19.492 21.772 24.5457 10.6799
融資現金流項目 -0.731 -1.008 -2.57481 -2.11755 0
股票的發行(報廢),淨額 35.615 7.756 24.4468 25.8797 10.302
債務的發行(退還),淨額 9.053 12.744 -0.1 0.78349 0.37791
現金淨變化 8.961 4.207 1.31519 1.80832 -0.70241
Deferred Taxes 0 -13.1812
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -18.164 -52.6 -38.282 -26.09 -12.009
Cash From Operating Activities -7.695 -34.97 -26.047 -16.615 -6.708
Cash From Operating Activities 0.426 1.719 1.29 0.861 0.431
Non-Cash Items 7.583 13.644 10.601 7.609 4.695
Cash Interest Paid 0.011 0.028 0.021 0.008 0.006
Changes in Working Capital 2.46 2.267 0.344 1.005 0.175
Cash From Investing Activities -0.006 -10.484 -0.006 0
Capital Expenditures -0.006 -0.006 -0.006 0
Cash From Financing Activities 8.15 43.937 40.816 40.443 30.868
Financing Cash Flow Items -0.335 -0.731 -0.623 -0.268 -0.095
Issuance (Retirement) of Stock, Net 9.11 35.615 32.386 31.608 21.86
Issuance (Retirement) of Debt, Net -0.625 9.053 9.053 9.103 9.103
Net Change in Cash 0.405 8.961 4.285 23.822 24.16
Other Investing Cash Flow Items, Total -10.478
Foreign Exchange Effects -0.05

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Bio Therapeutic Drugs

200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US

收入報表

  • Annual
  • Quarterly

人們也觀看

US100

12,962.30 Price
-0.040% 1D Chg, %
多頭倉位隔夜費用 -0.0249%
空頭倉位隔夜費用 0.0027%
隔夜費時間 21:00 (UTC)
價差 1.8

Gold

1,974.25 Price
-0.310% 1D Chg, %
多頭倉位隔夜費用 -0.0180%
空頭倉位隔夜費用 0.0098%
隔夜費時間 21:00 (UTC)
價差 0.30

Natural Gas

2.15 Price
+1.180% 1D Chg, %
多頭倉位隔夜費用 -0.4392%
空頭倉位隔夜費用 0.4173%
隔夜費時間 21:00 (UTC)
價差 0.006

Oil - Crude

73.95 Price
-0.620% 1D Chg, %
多頭倉位隔夜費用 -0.0170%
空頭倉位隔夜費用 -0.0049%
隔夜費時間 21:00 (UTC)
價差 0.03

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易